2019
DOI: 10.1007/s12519-018-0218-7
|View full text |Cite
|
Sign up to set email alerts
|

Association between fetal macrosomia and risk of obesity in children under 3 years in Western China: a cohort study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
32
0
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 41 publications
(38 citation statements)
references
References 27 publications
5
32
0
1
Order By: Relevance
“…On the other hand, macrosomia is an independent risk factor of child obesity [31,32]. This fact is especially relevant as macrosomia is seen as an intermediate factor in the relationship between maternal obesity and child obesity.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, macrosomia is an independent risk factor of child obesity [31,32]. This fact is especially relevant as macrosomia is seen as an intermediate factor in the relationship between maternal obesity and child obesity.…”
Section: Discussionmentioning
confidence: 99%
“…Low birth weight, defined as <2500 g, increases the likelihood of childhood obesity and subsequent metabolic health morbidities, such as type 2 diabetes [3][4][5][6][7]. Fetal macrosomia (often defined as ≥4000 g) reflects infants large for gestational age at birth and can also influence childhood weight gain and obesity risk [8][9][10]. Numerous maternal characteristics may positively or negatively impact infant birth weight, including smoking, nutrition, and hypertension [11].…”
Section: Introductionmentioning
confidence: 99%
“…The selected maternal and pregnancy characteristics and pregnancy outcomes included the following: gestational hypertension (BP ≥140/90 mmHg after 20 weeks in previously normotensive women), preeclampsia (hypertension and proteinuria, evidence of other maternal organ dysfunction, or uteroplacental dysfunction), preterm pre-eclampsia (if preeclampsia occurred at <37 gestational weeks) [15], GDM (diabetes diagnosed during pregnancy) [16], delivery method, intrahepatic cholestasis of pregnancy (ICP, characterized by an underlying elevation in circulating bile acids and liver derangement) [17], placenta previa (lower placenta edge within 2 cm from the internal os) [18], placenta accreta (a spectrum disorder ranging from abnormally adherent to deeply invasive placental tissue) [18], placental abruption (a premature separation of the placenta before delivery) [19], preterm premature rupture of membranes (pPROM, membrane rupture before labor and before 37 weeks of gestation) [20], chorioamnionitis (histological or clinical) [21], postpartum hemorrhage (an estimated blood loss in excess of 500 ml after a vaginal birth or a loss of greater than 1000 ml after a caesarean birth) [22], polyhydramnios (US assessment showing a largest, deepest pool of AF greater than 8 cm or an amniotic uid index greater than 25 cm), oligohydramnios (US assessment showing a largest, deepest pool of AF less than 2 cm or an amniotic uid index less than 2 cm) [23], preterm birth (PB or PTB, delivery after at least 28 weeks' gestation but no more than 37 weeks' gestation) [24], low birthweight (LBW, birthweight <2500 g) [24], macrosomia (birth weight ≥4000 g) [25], small for gestational age (SGA, de ned as birth weight below the 10th percentile of a standard optimal reference population for a given gestational age and sex) [26], Apgar score at 1 minute, Apgar score at 5 minutes and neonatal intensive care unit (NICU) admission.…”
Section: Variables Of Interest and De Nition Of Main Outcomesmentioning
confidence: 99%